A Foundation of Facts for Solid Treatment Plans
You won’t find many (or any) of our treatments at mainstream medical health providers. Between their desire to receive money from the federal government and their connections with major pharmaceutical companies, they ignore ketamine’s proven benefit for people who suffer from chronic depression.
We don’t ignore it. We also don’t ignore the studies done at the National Institutes of Mental Health, Mayo Clinic, Mt. Sinai School of Medicine, and Yale—which have shown significant benefit with the use of low-dose ketamine infusions for depression.
In other words, giving ketamine intravenously has been clinically proven to be effective. That’s why it’s our initial treatment method of choice for all patients.
A History of Results for Ketamine Research
Ketamine is an anesthetic that has been used on both humans and animals for over 50 years. In that time, a great deal of clinical research has been conducted by leading institutions all over the world, proving intravenous ketamine’s efficacy and safety in the treatment of major depression, bipolar depression, PTSD, and severe anxiety, as well as certain pain disorders. These studies regularly report a 70% success rate or higher.
For some patients, ketamine infusion therapy is quite simply life-changing, and it is unlike any other treatment currently available given its rapid, robust effects and lack of side effects between treatments.
Schedule a Free Consultation Today
While the internet is a great place to get basic information, a personal, in-depth consultation with Dr. Ayesha McCoy helps you make informed decisions about finding help and hope for depression, anxiety, and chronic pain.
